Vericel Corp Ord share price logo

Vericel Corp Ord

NASDAQ: VCEL

Small Cap

$32.71

-0.23

(-0.70%)

Live

as on

Vericel Corp Ord Stock Performance

as on May 14, 2026 at 4:12 am IST

  • Day's Low

    Day's High

    $32.01
    $33.45
    downward going graph

    2.14%

    Downside

    2.26%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $28.95
    $45.97
    downward going graph

    11.49%

    Downside

    40.54%

    Upside

    downward going graph

Vericel Corp Ord share price movements today

Previous Close
$32.94
Open
$32.31
Volume
388.2K
Day's Low - High
$32.01 - $33.45
52 Week Low - High
$28.95 - $45.97

Vericel Corp Ord Historical Returns

1 Month Return
-4.36 %
3 Month Return
-8.4 %
1 Year Return
-24.52 %
3 Year Return
+ 0.46 %
5 Year Return
-31.17 %

Vericel Corp Ord Stock Fundamentals & Key Indicators

Check Vericel Corp Ord market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.7B

EPS (TTM)

0.4625

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.19%

PE Ratio (TTM)

76.56

Industry PE ratio

-3.7867796610169493

PEG Ratio

0

EBITDA

27.9M

Revenue (TTM)

292.1M

Profit Margin

7.35%

Return On Equity TTM

6.59%

Vericel Corp Ord Stock Valuation

Track how Vericel Corp Ord P/E has moved over time to understand its valuation trends.

Vericel Corp Ord in the last 5 years

  • Overview

  • Trends

Lowest (-150.74x)

September 30, 2023

Industry (-3.79x)

May 13, 2026

Today (76.56x)

May 13, 2026

Highest (149.61x)

September 30, 2025

LowHigh

Today’s Price to Earnings Ratio: 76.56x

Vericel Corp Ord vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Vericel Corp Ord with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Vericel Corp Ord image
Vericel Corp Ord
BUY$1.7B-31.17%76.567.35%
Alnylam Pharmaceuticals Inc image
Alnylam Pharmaceuticals Inc
BUY$38.0B119.7%71.3912.55%
BeiGene, Ltd. image
BeiGene, Ltd.
NA$32.7BNA71.448.94%
Vertex Pharmaceuticals Inc image
Vertex Pharmaceuticals Inc
BUY$110.4B109.14%25.8435.51%
Regeneron Pharmaceuticals Inc image
Regeneron Pharmaceuticals Inc
BUY$74.7B39.88%17.3929.65%

Stock Returns calculator for Vericel Corp Ord Stock including INR - Dollar returns

The Vericel Corp Ord stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Vericel Corp Ord investment value today

Current value as on today

₹84,122

Returns

-₹15,878

(-15.88%)

Returns from Vericel Corp Ord Stock

-₹25,046 (-25.05%)

Dollar Impact

₹9,168 (+9.17%)

Analyst Recommendation on Vericel Corp Ord Stock

Based on 12 analysts

BUY

91.67%

Buy

8.33%

Hold

0.00%

Sell

Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Vericel Corp Ord. Average target price of $55.43

Vericel Corp Ord Share Price Target

Get share price movements and forecasts by analysts on Vericel Corp Ord.

What analysts predicted

40.99%UPSIDE

Target Price

$55.43

Current Price

$32.71

Analyzed by

12 Analysts

Target

$55.43

Vericel Corp Ord target price $55.43, a slight upside of 40.99% compared to current price of $32.71. According to 12 analysts rating.

Indian Investors' Interest in Vericel Corp Ord Stock

Search interest for Vericel Corp Ord Stock has increased by 107% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:107% versus previous 30 day period

Vericel Corp Ord Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
64
51
52
57
75
52
63
67
92
68
Gross Profit
48
35
36
41
58
36
46
49
73
49
Operating Income
12
-5
-6
-2
18
-12
-2
3
22
-8
EBITDA
15
-2
-3
0
21
-8
2
8
27
-4
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
1
1
1
1
1
2
2
2
3
-
Income Before Tax
14
-3
-4
0
19
-11
0
5
24
-6
Income Tax Expense
1
1
-
-
0
-
-
-
0
-
Net Income
12
-3
-4
0
19
-11
0
5
23
-6
Net Profit Margin
19.99%
-7.53%
-8.89%
-1.56%
26.28%
-21.38%
-0.87%
7.52%
25.01%
-9.21%

Vericel Corp Ord Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
54
63
90
117
124
156
164
197
237
276
Gross Profit
26
33
58
80
84
106
109
135
172
205
Operating Income
-19
-14
-3
-11
2
-7
-17
-6
4
11
EBITDA
-17
-14
-4
-7
5
-4
-11
2
16
30
Interest Expense
0
1
1
0
0
0
0
0
0
1
Depreciation
-
1
1
1
2
2
3
4
5
11
Income Before Tax
-19
-17
-8
-9
3
-7
-15
-2
10
17
Income Tax Expense
2
1
3
-1
0
0
0
0
0
0
Net Income
-19
-17
-8
-9
2
-7
-16
-3
10
16
Net Profit Margin
-35.98%
-27.04%
-8.96%
-8.20%
2.31%
-4.78%
-10.17%
-1.61%
4.37%
5.98%

Vericel Corp Ord Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-3
-4
0
19
-11
0
5
23
-
Operating Cash Flow
7
18
10
22
6
8
22
15
16
Investing Cash Flow
-25
-17
-21
-14
-15
-9
-3
-16
-4
Financing Cash Flow
2
4
5
7
3
1
1
1
-2
Change in Cash
-16
5
-5
14
-5
0
19
0
9

Vericel Corp Ord Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-17
-8
-9
2
-7
-16
-3
10
16
Operating Cash Flow
-13
0
-7
17
29
17
35
58
51
Investing Cash Flow
-1
-67
10
-17
-3
-36
-3
-79
-43
Financing Cash Flow
18
58
5
6
9
1
3
19
7
Change in Cash
3
-8
8
6
34
-17
35
-1
15

Global Institutional Holdings in Vericel Corp Ord

Funds
Holdings
Morgan Stanley - Brokerage Accounts
1.37%
Amvescap Plc.
1.46%
BlackRock Inc
15.09%
GW&K Investment Management, LLC
3.1%
Allspring Global Investments Holdings, LLC
1.37%
See all

Insights on Vericel Corp Ord

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, BeOne Medicines Ltd has given 40.2% return, outperforming this stock by 64.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 32.2% return, outperforming this stock by 31.7%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 23.24M → -6.30M (in $), with an average decrease of 127.1% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, VCEL stock has moved down by -10.4%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 92.91M → 68.42M (in $), with an average decrease of 26.4% per quarter

About Vericel Corp Ord

Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports medicine and severe burn care markets in North America. The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns; and NexoBrid, a biological orphan product for eschar removal in adults and pediatric patients with deep partial-thickness and/or full-thickness thermal burns. Vericel Corporation was formerly known as Aastrom Biosciences, Inc. and changed its name to Vericel Corporation in November 2014. The company was incorporated in 1989 and is headquartered in Cambridge, Massachusetts.
OrganisationVericel Corp Ord
Headquarters64 Sidney Street, Cambridge, MA, United States, 02139
IndustryBiotechnology
CEOMr. Dominick C. Colangelo Esq.
E-voting on sharesClick here to vote

Key Management of Vericel Corp Ord

Name

Title

Mr. Michael Halpin

Chief Operating Officer

Mr. Sean C. Flynn

Chief Legal Officer

Mr. Jonathan D. Siegal

Principal Accounting Officer, VP & Corporate Controller

Mr. Mike Gilligan

Senior Vice President of Sales

Mr. Roland DeAngelis

Chief Marketing Officer

Mr. Patrick J. Fowler

Senior Vice President of Corporate Development & Strategy

Mr. Dominick C. Colangelo Esq.

CEO, President & Director

Mr. Joseph Anthony Mara Jr.

CFO & Treasurer

Dr. Jonathan M. Hopper FRCSEd., M.B. Ch.B.

Chief Medical Officer

Mr. Eric Burns

Vice President of Finance & Investor Relations

FAQs

What is Vericel Corp Ord share price today?

Vericel Corp Ord share price today is $32.71 as on . Vericel Corp Ord share today touched a day high of $33.45 and a low of $32.01.

What is the 52 week high and 52 week low for Vericel Corp Ord share?

Vericel Corp Ord share touched a 52 week high of $45.97 on and a 52 week low of $28.95 on . Vericel Corp Ord stock price today i.e. is trending at $32.71,which is 28.84% down from its 52 week high and 12.99% up from its 52 week low.

What is Vericel Corp Ord's market capitalisation today?

Vericel Corp Ord market capitalisation is $0.00T as on .

How to invest in Vericel Corp Ord Stock (VCEL) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Vericel Corp Ord on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Vericel Corp Ord Shares that will get you 0.0459 shares as per Vericel Corp Ord share price of $32.71 per share as on May 13, 2026 at 10:42 pm IST.

What is the minimum amount required to buy Vericel Corp Ord Stock (VCEL) from India?

Indian investors can start investing in Vericel Corp Ord (VCEL) shares with as little as ₹95.705 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹957.05 in Vericel Corp Ord stock (as per the Rupee-Dollar exchange rate as on ). Based on Vericel Corp Ord share’s latest price of $32.71 as on May 13, 2026 at 10:42 pm IST, you will get 0.3057 shares of Vericel Corp Ord. Learn more about fractional shares .

What are the returns that Vericel Corp Ord has given to Indian investors in the last 5 years?

Vericel Corp Ord stock has given -31.17% share price returns and 29.72% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?